Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Erectile dysfunction (ED) affects up to one-third of men at some point in their lives, not only preventing them from enjoying intercourse with their partners but also creating a tremendous amount of shame and anxiety.1 2 Moreover, in about 40% of cases, even the most well-known and effective ED drugs fail to produce a satisfactory response owing to side effects or ineffectiveness.13 In those cases, the peptide PT-141 has shown some promise as an unconventional alternative or adjunct treatment
Peptide Sequence (IUPAC Condensed): Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH Molecular Formula: C50H68N14O10 Molecular Weight: 1025.2 g/mol Synonyms: Bremelanotide View the PT-141 Certificate Of Analysis (COA) PT-141 works by activating melanocortin receptors, specifically the MC3-R and MC4-R receptors, in the central nervous system
Clinical Trial Evidence The head-to-head comparison comes from the SURPASS clinical trial program for diabetes and SURMOUNT program for weight loss
Step 3: Timing
Perimenopause, postpartum sleep, and inflammation Three questions from paid subscribers this week, all from women on a GLP-1
Front Mol Neurosci (2017) 10:167
US$ 29.31
US$ 26.99
US$ 28.82
US$ 29.46
